Reading: Relationship between Cholesterol Levels and Suicide Attempts in Chronic Psychosis

PDF Cite A- A+

Citation

Ahmet Ziya Sahin, Sengul Sahin, Sakir Ozgur Keskek; Relationship between Cholesterol Levels and Suicide Attempts in Chronic Psychosis, Trends Journal of Sciences Research, Volume 3, Issue 3, October 10, 2018, Pages 133-137. 10.31586/Psychiatry.0303.05


Download citation file:

ABNTAPABibTeXCBEEndNoteMLARefWorksTurabianProCite - RISRefManCitationPlugin

Research Article

Open Access

Peer Reviewed

Under a Creative Commons license

Article Contents

Relationship between Cholesterol Levels and Suicide Attempts in Chronic Psychosis

Trends Journal of Sciences Research, Volume 3, Issue 3, 2018, Pages 133–137.

https://doi.org/10.31586/Psychiatry.0303.05

Received September 04, 2018; Revised October 07, 2018; Accepted October 09, 2018;
Published October 10, 2018

Abstract

Objective: Suicide is the most common cause of premature death of schizophrenia. This study investigated the relationship between cholesterol levels and suicidal behaviour in chronic psychosis. Methods: The study group consisted of 109 schizophrenia, schizoaffective and other non affectice psychosis defined by Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) criteria. Lifetime suicide attempts of patients were retrospectively screened. The patients were divided into two groups with and without suicide. Serum cholesterol levels were compared between two groups. Results: The mean total cholesterol, triglyceride, HDL and LDL levels were 163.8 mg/dl,150.8 mg/dl,40.8 mg/dl and 132.4 mg/dl, respectively in the study group while they were 197.1 mg/dl, 194 mg/dl, 44.9 mg/dl and 124.2 mg/dl, respectively in the control group. Total cholesterol levels were significantly lower than patients with suicidal attempts compared with the patients with no suicidal attemps (p=0,03). No association was found between suicidal attempt and HDL cholesterol (p=0,24), triglyceride (p=0,193), and LDL(p=0,45). Conclusion: This result supports the hypothesis of association low plasma cholesterol levels and suicidal behavior in psychosis

1. Introduction

Suicide is the most common cause of premature death of schizophrenia 1. Suicide rates in psychotic patients were 8.6% before the first hospital admission and 5.3% in the first year of treatment 2. Age, severity of depressive symptoms, aggressive and impulsive personality characteristics are factors that increase risk of suicide 3. Surveys show that recurrent suicide attemps in psychosis are high regardless of whether patients are treated with ot without hospitalization 4. Previous suicide attempts are considered the strongest predictor of future suicide attempts 5. Many researchers have focused on investigating biomarkers that may be related to suicide in order to prevent and treat suicidal behavior. Metabolic dysregulation; altered lipid profile, especially low total cholesterol and LDL levels, was associated with higher risk of suicide in schizophrenic patients 6. The relationship between low cholesterol and increased risk of suicide has also been reported in impulsive aggressive behavior, mood disorders, substance abuse, psychosis, and personality disorders 7. It’s unclear how calm low cholesterol may be related to brain function mediated by suicidal behavior 8. Postmortem brain studies have shown that patients with violent suicide attempts have lower gray matter cholesterol content, especially frontal cortex when compared to nonviolent suicides 9.

In this study, lipid and lipoprotein profiles were examined in patients with schizophrenia and other psychotic patients with or without suicide attempt. We aimed to confirm whether the change in lipid profile has increased the risk of suicide in patients with psychosis.

2. Materials and Methods

This retrospective study was carried out in psychiatry clinics of Community Mental Health Center, Turkey, between October 2016 and July 2017. Serum lipid levels were measured as part of a routine screening in all psychosis patients once in six monthly sessions. The total sample consisted of 63 schizophrenia, 16 schizoaffective and 30 other non affectice psychosis. Schizophrenia, schizoaffective and other non affectice psychosis was diagnosed by psychiatrists according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders 5th Edition.

The lipid levels were perfermed by enzymatic methods for total cholesterol (TC) and triglyceride (TG), and clearance methods for high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C).

Anthropometric measurements are measured on the same digital medical scale. The weight is measured with a digital scale. BMI was calculated by dividing the height by weight in square meters (kg/m2).

The exclusion criteria were as follows: aged under 18 years old or above 65 years old, substance abuse or dependence, the presence of non mental chronic medical illness, pregnancy, dementia, moderate or severe mental retardation.

Patient's length, body weight, waist circumference were measured. Body mass index were calculated. Triglyceride, HDL, LDL, total cholesterol levels were recorded.

Statistical analyses were performed using the SPSS 23.0 software package and the significance level used was p < 0.05. Relationships between discontinuous variables were tested by chi-square analysis. The compliance of the data with a normal distribution is analyzed via the Shapiro-Wilk test. In comparison of two independent groups, the Student’s t-test was used to compare means between continuous variables, Mann Whitney U Test was used for variables that don’t have normal distribution.

3. Results

In total, we enrolled 109 schizophrenia, schizoaffective disorder and other psychosis (61,5% male). The average age of these patients was 39,3 years, desease onset age was 21,4, the number of hospitalizations was 6.4. Sociodemographic and clinical features of patients are shown in Table 1.

The average age of the patients with suicide attempt was 38±9.4 years and the mean age of those without suicide attempt was 40.5±13 years. There were no statistically significant differences between the groups in terms of age, gender smoking rates, body mass index, formal education (p>0.05). (Table 1)

Table 1. Sociodemographic and Clinical Characteristics of Patients

Mean total cholesterol, triglyceride, HDL and LDL levels were 161 mg/dl, 167 mg/dl, 43 mg/dl and 1234 mg/dl respectively in patients who had made at least one suicidal attempt all through life. Mean total cholesterol, triglyceride, HDL and LDL levels were 193 mg/dl, 189 mg/dl, 47 mg/dl and 122 mg/dl respectively in the control group. Total cholesterol levels were significantly lower in patients with suicidal attemps compared with the patients with no suicidal attemps (p=0,04). No association with suicidal attempst was found with HDL cholesterol (p=0,78), triglyceride (p=0,46) and LDL(p=0,25) in subjects studied (Table 2).

Table 2. Frequency of suicidal attemps of patients who have chronic psychosis

A weakly/moderately positive-correlation was found between the total number of hospitalisations in patients with psychosis and triglyceride levels (r: +0,239, p: 0,045). The mean number of suicidal attemp was 0,72±1,7 in the study group. A weakly/moderately inverse-correlation was found between the total number of suicid attemps in patients with psychosis and total cholesterole levels (r: -0,300, p: 0,02).

4. Discussion

In this study, we investigated the association of suicide attempts with total cholesterol and lipoprotein profiles in psychotic patients who had an episod of suicide attempt and without any suicidal behavior.

Previous reports have not found differ between patients with and without suicidal attempt with respect to demographic variables 10. Similiarly in our study there were no statistically significant differences between the groups in terms of age, gender smoking rates, body mass index, formal education.

Previous studies suggested that altered lipid profile, including low total cholesterol (TC) and low-density lipoprotein-cholesterol (LDL-c) levels, is associated with high suicide risk in schizophrenic patients 6, 11, 12, 13. In our study, total cholesterol levels were lower in all chronic psychotic patients who had an apisode of suicide attempt similar to previous studies. There was no difference between patients with and without suicide attempt at triglyceride, HDL, LDL cholesterol levels.

High suicide rates in early psychotic patients have been reported consistently in studies 14. In addition, it has been reported that low cholesterol levels are associated with severe suicidal ideation in early psychotic patients 15. In our study, we found a similar relationship between the high suicide attempt rate (33%) and low total cholesterol level in the chronic period of the disease. Contrarily, in a retrospective study of 213 psychiatric patients, researchers found no difference in serum cholesterol levels between patients with and without suicide attempts 16.

A study analyzed the brain oxysterol levels, the enzymatic oxidation products of cholesterol, in the prefrontal cortex of suicide victims. Their results show a significant increase in 24-hydroxysterol, which reflects a higher turnover of cholesterol. They suggest that this metabolic process may be responsible for a reduction in central and peripheral cholesterol in these patients 16. Finally, low lipid levels in schizophrenia patients may also be associated with metabolic syndrome. The incidence of metabolic syndrome in patients with schizophrenia was found lower than in patients without suicide attempt 17. The relationship between serum cholesterol and suicidal behavior is also explained by the hypothesis that low serum cholesterol levels may cause decreased central serotonergic activity with changes in viscosity and function of serotonin receptors and carriers 18.

Some methodological limitations should be considered in the interpretation of our results; the small sample size of the groups studies, dietary differences that affect serum cholesterol levels. Additionally, retrospective study design may be an another limitation.

In conclusion, this study has contributed to many of the studies showing the relationship between suicidal behavior and lower total plasma cholesterol levels. Therefore, in patients with chronic psychosis we support the role of plasma cholesterol as a biological status indicator in the evaluation of suicide risk.

5. Conflict of Interest

The authors declare that there are no conflicts of interest.

6. Ethics Approval and Consent to Participate

This retrospective study was carried out in psychiatry clinics of the Adana State Hospital Community Mental Health Center, Turkey, between October 2016 and July 2017. The institutional review board approved this study. This study was approved by the Ethics Committee. All procedures were followed in accordance with the Good Clinical Practice standards and with the Helsinki Declaration of 2008.

References

[1]
Palmer BA, Pankratz VS, Bostwick JM. The life time risk of suicide in schizophrenia: a reexamination. Arch Gen Psychiatry. 2005; 62:247-253
[2]
Shrivastava A, Shah N, Johnston M, Stitt L, Thakar M. Predictors of long-termoutcome of first-episode schizophrenia: A ten-year follow-up study. Indian J Psychiatry. 2010; 52:320–326
[3]
Barak Y, Baruch Y, Achiron A, Aizenberg D. Suicide attempts of schizophrenia patients: a case-controlled study in tertiary care. J PsychiatrRes. 2008; 42:822-826.
[4]
Pompili M, Serafini G, Innamorati M, Lester D, Shrivastava A, Girardi P, Nordentoft M. Suicide risk in first episode psychosis: A selective review of the current literature. Schizophr Res. 2011;129:1–11.
[5]
Goldacre M, Seagroatt V, Hawton K. Suicide after discharge from psychiatric inpatient care. Lancet. 1993;342:283–6
[6]
Ainiyet B, Rybakowski JK. Suicidal behavior in schizophrenia may be related to low lipid levels. Med Sci Monit. 2014;20:1486–1490
[7]
Kim YK, Lee HJ, Kim JY, Yoon DK, Choi SH, Lee MS. Low serum cholesterol is correlated to suicidality in a Korean sample. Acta Psychiatr Scand. 2002;105:141–148.
[8]
Ernst C, Mechawar N, Turecki G. Suicide neurobiology. Prog Neurobiol. 2009;89:315–333
[9]
Lalovic A, Levy E, Luheshi G, Canetti L, Grenier E, Sequeira A, Turecki G. Cholesterol content in brains of suicide completers. Int J Neuropsychopharmacol. 2007;10:159–166
[10]
Uzun O, Tamam L, Ozculer T, Doruk A, Unal. Specific characteristics of suicide attempts in patients with schizophrenia in Turkey. Isr J Psychiatry Relat Sci. 2009;46:189-194.
[11]
Atmaca M, Kuloglu M, Tezcan E, Ustundag B. Serum leptin and cholesterol levels in schizophrenic patients with and without suicide attempts. Acta Psychiatr Scand. 2003;108:208–214.
[12]
Marcinko D, Martinac M, Karlović D, Loncar C. Cholesterol serum levels in violent and non-violent young male schizophrenic suicide attempters. Psychiatr Danub. 2004;16:161–164.
[13]
Marcinko D, Martinac M, KarloviC D, Filipcić I, Loncar C, Pivac N, Jakovljević M. Are there differences in serum cholesterol and cortisol concentrations between violent and non violent schizophrenic male suicide attempters? CollAntropol. 2005;29:153–157.
[14]
Tarrier N, Khan S, Cater J, Picken A. The subjective consequences of suffering a firs tepisode psychosis: Trauma and suicide behaviour. Soc Psychiatry Psychiatr Epidemiol. 2007;42:29–35
[15]
Shrivastava A, Johnston M, Campbell R, Sousa AD, Shah N. Serum cholesterol and Suicide in first episode psychosis: A preliminary Study. Indian J Psychiatry. 2017; 59: 478–482.
[16]
Lester D. Serum cholesterol levels and suicide: A meta-analysis. Suicide Life Threat Behav. 2002;32:333–46
[17]
Freemantle E, Chen GG, Cruceanu C, Mechawar N, Turecki G. Analysis of oxysterols and cholesterol in prefrontal cortex of suicides. Int J Neuro-psychopharmacol. 2013;16:1241–1244
[18]
Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M. Serum cholesterol and serotonergic function in majör depressive disorder. PsychiatryRes. 2003;9:137–145